A research team from Queen’s University Belfast, in collaboration with an international team of experts, have made ground-breaking insights into how inflammatory diseases work.
When compared with nondrinkers, men and women who had one or more alcoholic drinks per day had an overabundance of oral bacteria linked to gum disease, some cancers, and heart disease. By contrast, drinkers had fewer bacteria known to check the growth of other, harmful germs.
How a bacteria hijacked insect fertility remained a mystery for five decades, until Associate Professor of Biological Sciences Seth Bordenstein and his team helped solve it.
One of the most frustrating and debilitating complications of diabetes is the development of wounds on the foot or lower leg. Once they form, they can persist for months, leading to painful and dangerous infections.
A $2 million investment from a Denver angel investor group is the latest step forward for the biomedical startup CNine Biosolutions. Two entrepreneurs are using technology they developed at UAB to create a rapid and simple test to distinguish bacterial meningitis from viral meningitis.
Johns Hopkins scientist Steven Salzberg, Ph.D., known for his ability to tackle the most difficult projects in genome sequencing, has been elected as a member of the American Academy of Arts and Sciences. He joins the group of 213 scientists, scholars, writers, artists and other leaders, including former President Barack Obama and Supreme Court Justice Sonia Sotomayor, who make up the class of 2018.
Wistar and partners at the Perelman School of Medicine, University of Pennsylvania; Inovio Pharmaceuticals; and GeneOne Life Science were recognized among the Top 10 Clinical Research Achievement Awards by the Clinical Research Forum for their groundbreaking phase 1 DNA-based Zika vaccine research – the first trial of a Zika vaccine in humans, which proved safe and effective.
More than one in five fawns of white-tailed deer – the most economically important big-game mammal in the United States – can contract a malaria parasite, making fawns susceptible to diseases and death, a new study co-authored by a University of Florida researcher shows.
An international team focused on HIV cure research spearheaded by The Wistar Institute in collaboration with the University of Pennsylvania and Vall d’Hebron Research Institute (VHIR) in Barcelona, Spain, established that the CD32 molecule is not a preferential biomarker to identify HIV silent reservoirs within the immune system of patients undergoing antiretroviral therapy (ART), as proposed by a recent landmark study.
Researchers at the University of Minnesota and The Dow Chemical Company have joined forces to tackle one of the biggest challenges in health care—how to get life-saving medicines to work faster and better with fewer side effects.
University of Georgia food scientist Xiangyu Deng has created a system that can identify foodborne pathogens in a fraction of the time taken by traditional methods.
Studying mice, researchers have found that a drug called nalfurafine hydrochloride (Remitch) can deliver itch relief by targeting particular opioid receptors on neurons in the spinal cord. The new study suggests that the drug may be effective against many types of chronic itching that don’t respond to conventional drugs such as antihistamines.
The National Institute of Allergy and Infectious Diseases has awarded a five-year, $15 million grant to the San Diego Center for AIDS Research (CFAR) at UC San Diego, renewing support that extends back to an original establishing grant in 1994—the height of the AIDS epidemic.
Taking the road home to Baltimore rewards an HIV researcher and a community-minded caregiver. The city provides fertile ground for their contributions.
Even the briefest increase in airborne fine particulate matter PM2.5, pollution-causing particles that are about 3 percent of the diameter of human hair, is associated with the development of acute lower respiratory infection (ALRI) in young children, according to newly published research.
Increases in PM2.5 levels also led to increased doctor visits for these lung infections.
It’s a simple idea: Pair the control of a neglected tropical disease with a more prominent disease that afflict the same populations to reduce morbidity and mortality. The approach could be a win-win, but for public health officials, having evidence to support implementation of an integrated approach is vital.
Researchers have shown, in mice, that norovirus infects a rare type of intestinal cell called a tuft cell. Inside tuft cells, norovirus is effectively hidden from the immune system, which could explain why some people continue to shed virus long after they are no longer sick. These “healthy carriers” are thought to be the source of norovirus outbreaks, so understanding how the virus evades detection in such people could lead to better ways to prevent outbreaks.
Despite its substantial impact on pregnancy outcomes, scientists know little about how group B streptococcus (GBS) establishes an in utero infection. In a paper published in the Journal of Clinical Investigation, Dr. Lakshmi Rajagopal, a principal investigator in Seattle Children’s Research Institute Center for Global Infectious Disease Research describes a newly uncovered mechanism by which GBS gains access to a woman’s uterus.
Across the world, over 200 million cases of malaria and nearly 500,000 deaths from the disease occur annually—more than 90 percent of which happen in Africa. Children in Africa can be diagnosed with malaria two or three times a year, a rate that decreases as they become older and develop immunity. But the way children generate and maintain this immunity remains a mystery. Katherine Dobbs, MD, a tropical infectious diseases and malaria researcher, is conducting research in Kenya to find answers by studying white blood cells important to innate immunity, the body’s “first response” to infection.
Fred Hutchinson Cancer Research Center’s latest findings will be featured in about 50 presentations at the annual meeting of the American Association for Cancer Research, “Driving Innovative Cancer Science to Patient Care,” to be held April 14-18 in Chicago. Here are several highlights:
Tick-borne illnesses are a growing problem on Long Island, and a new season is about to begin. To prepare for this and inform the public, Stony Brook Medicine experts are tackling the topic head on at an April 12 symposium.
New research from The Ohio State University offers a glimpse into the complexity of interactions between bacteria and the viruses – or phages – that infect them.
Researchers at the University of Chicago have developed a genetic screening tool that identified two key factors that allow the influenza virus to infect human lung cells. The technique uses new gene editing tools to create a library of modified cells, each missing a different gene, allowing scientists to see which changes impact their response to flu. This in turn could identify potential targets for antiviral drugs.
Clostridium difficile infection (CDI) is now the most common hospital-acquired infection, with significant effects on healthcare costs. Surgeons from George Washington University Hospital sought to identify rates of C. difficile infection in patients undergoing common types of colon operations. The authors utilized the American College of Surgeons NSQIP database for 2015 to retrospectively review all cases of elective ileostomy and colostomy reversals.
Researchers at the University of Notre Dame focused on an enzyme in gram-negative bacterium Pseudomonas aeruginosa, a pathogen that causes pneumonia and sepsis.
Researchers at Harvard Medical School, the University of California, San Francisco, and the University of Georgia have described how the protein that allows strep and staph bacteria to stick to human cells is prepared and packaged. The research, which could facilitate the development of new antibiotics, will appear in the April 6 issue of the Journal of Biological Chemistry.
A new blood test has been found to more accurately predict the development of tuberculosis up to two years before its onset in people living with someone with active TB, according to research published online in the American Journal of Respiratory and Critical Care Medicine, an American Thoracic Society journal.
• The risk of death due to infectious causes after kidney transplantation in Finland has dropped by half since the 1990s.
• Common bacterial infections remain the most frequent cause of infection-related deaths among transplant recipients.
In the April 5, 2018 issue of the journal Cell, researchers push for greater emphasis on the neglected viral-surface influenza protein neuraminidase. For decades, flu vaccines have concentrated on hemagglutinin. The authors maintain that a focus on neuraminidase could lower infection rates and lessen severity.
UNC School of Medicine researchers have identified mutations to the bacterium Neisseria gonnorrhoeae that enable resistance to ceftriaxone that could lead to the global spread of ceftriaxone-resistant “superbug” strains.
With research showing that male circumcision reduces the odds of getting HIV through heterosexual sex by 60 percent, more boys and young men – primarily those between the ages of 10 and 19 – are having the procedure done, largely in eastern and southern African nations where circumcision is rarely performed at birth.
Seven of the 11 animal viruses tested can potentially survive the transglobal journey from Asia or Europe to the United States in at least two commonly imported feed ingredients. That means feed biosecurity should be a major priority.
The Fred Hutch Tip Sheet includes story ideas about: New paths to malaria prevention; proteins involved in muscular dystrophy; pathogen-associated cancers; lung cancer in women who never smoked; financial impact of cancer care; more
One way to fight diseases including HIV infection and autoimmune disorders could involve changing how a naturally occurring enzyme called SAMHD1 works to influence the immune system, new research suggests.
Vincenzo Venditti, an assistant professor of chemistry at Iowa State University, is searching for a new kind of antibiotic in the fight against antimicrobial-resistant superbugs.
Researchers at the University of Georgia have discovered that dormancy of the parasite Trypanosoma cruzi prevents effective drug treatment for Chagas disease, which kills more than 50,000 people each year in Central and South America and is a growing threat in the United States and Europe.
A team led by Berkeley Lab scientists has developed a process for creating ultrathin, self-assembling sheets of synthetic materials that can function like designer flypaper in selectively binding with viruses, bacteria, and other pathogens. The new platform could potentially be used to inactivate or detect pathogens.
Researchers and public health officials have struggled to explain the resurgence of whooping cough in the United States since the late 1970s, and the suspected shortcomings of the current generation of vaccines are often blamed.
But a new University of Michigan-led study concludes that the resurgence of the highly contagious respiratory disease is the result of factors—including a phenomenon known as the honeymoon period—that began in the middle of the last century, long before the latest vaccines were introduced in the late 1990s.
• Scientists untangle the structure of a recently discovered bacterial wall-building protein, found in nearly all bacteria
• The discovery unveils potential weak spots in the protein’s molecular make-up
• Findings can pave the way to next-generation broad-spectrum drugs that disrupt the protein’s function and disarm harmful bacteria
SUNY Downstate Medical Center (Downstate) launched a novel initiative to improve hand hygiene with the new state-of-the art BioVigil system to increase compliance by Downstate staff on proper hand hygiene to prevent the spread and transmission of infections.
Imagine a small paper device that can rapidly reveal from a drop of blood whether an infection is bacterial or viral. The device could help reduce the overuse of antibiotics – which kill bacteria, not viruses. Misuse of antibiotics has led to antimicrobial resistance, a growing global public health issue.